Entrada Therapeutics (TRDA) Interest & Investment Income (2020 - 2026)
Entrada Therapeutics (TRDA) reported Interest & Investment Income of $2.24 million for Q2 2026, down 43.0% from $3.92 million a year earlier and down 14.8% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Entrada Therapeutics' Interest & Investment Income came in at $11.57 million, down 39.9% year-over-year; for FY2025, it came in at $15.07 million, down 22.6% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of 153.5% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $19.47 million in FY2024 (+28.0%), $15.22 million in FY2023 (+478.2%), $2.63 million in FY2022 and -$31,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q4 2022.
- Year over year, Interest & Investment Income has now declined in each of the last five quarters, with an average decline of 13.0% over the last eight quarters.
- The high point for year-over-year Interest & Investment Income in five years was Q2 2023 (growth of 946.7%); the low point was Q2 2026 (a decline of 43.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.62 million (Q1 2026), $3.14 million (Q4 2025) and $3.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Entrada Therapeutics | 205.54 Mn | -172.82 Mn | - | 1.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.97 Mn |
| Jun 30, 2026 | 2.24 Mn |
| Mar 31, 2026 | 2.62 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Sep 30, 2025 | 3.57 Mn |
| Jun 30, 2025 | 3.92 Mn |
| Mar 31, 2025 | 4.44 Mn |
| Dec 31, 2024 | 5.13 Mn |
| Sep 30, 2024 | 5.77 Mn |
| Jun 30, 2024 | 4.37 Mn |
| Mar 31, 2024 | 4.21 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Sep 30, 2023 | 4.05 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 2.66 Mn |
| Dec 31, 2022 | 950,000.00 |
| Sep 30, 2022 | 799,000.00 |
| Jun 30, 2022 | 403,000.00 |
| Mar 31, 2022 | 480,000.00 |
| Dec 31, 2021 | 13,000.00 |
API Access
Entrada Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();